Protective Genetic Variants for Alzheimer Disease in the Amish
阿米什人阿尔茨海默病的保护性遗传变异
基本信息
- 批准号:9898659
- 负责人:
- 金额:$ 28.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgeAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAmishAmyloid beta-ProteinBiologicalBiologyCase-Control StudiesCell physiologyChromosomesCognitiveCollectionCommunitiesConsanguinityCoupledDNADataData LinkagesData SetDementiaDevelopmentDietEducational BackgroundEmotionalEnvironmental Risk FactorEtiologyFamilyFinancial HardshipFounder GenerationGene ExpressionGeneral PopulationGenerationsGenesGeneticGenetic Predisposition to DiseaseGenetic RiskGenetic TranscriptionGenetic VariationGenomicsGenotypeGoalsIn VitroInbreedingIndianaIndividualLife StyleMaintenanceMetabolismOhioOnset of illnessParentsPathway interactionsPhasePlayPopulationProcessPropertyProteinsQuality ControlResearchResearch DesignRiskRoleSNP genotypingSamplingScreening procedureSeriesSignal TransductionSurvival AnalysisTestingVariantVertebral columnWorkbasecandidate validationcase controlcognitive testingexomeexperimental studyfollow-upgenetic architecturegenetic associationgenetic linkage analysisgenetic pedigreegenetic risk factorgenetic variantgenome sequencinggenomic datanoveloffspringoverexpressionphenotypic dataprotein expressionrare variantreference genomerisk variantscreeningsuccesstau Proteinstransmission processwhole genome
项目摘要
ABSTRACT:
Alzheimer disease (AD) is the most common form of dementia in older individuals. Both genetic and
environmental factors contribute to AD risk, yet despite huge research efforts, a significant portion of the genetic
etiology of AD remains unexplained. Population-wide studies of unrelated AD cases and controls have identified
several common genetic risk factors and through the Alzheimer’s Disease Sequencing Project (ADSP) whole
exome (WES) and whole genome sequencing (WGS) data are being analyzed to identify AD risk modulators.
However, the primary focus of almost all of these studies has been on identifying variants that increase risk;
studies designed to identify variants that may protect from AD are few and usually underpowered. Thus,
additional strategies are required to identify functional variants that protect against or delay the
development of AD. The Amish provide a powerful and unique opportunity to identify variants protecting against
AD whilst controlling for some confounding factors such as level of education, lifestyle and diet. In addition, the
large Amish pedigrees offer an enrichment strategy for identifying rare variants since Mendelian transmissions
from parents to offspring, coupled to inbreeding loops, maximize the chance that multiple copies of rare variants
exist. The primary goal of this project is to identify genetic variations offering protection against AD. The project
will achieve this goal by pursuing three specific aims: (1): Generation of a family-based Amish AD Protective
Variant dataset. We will collect DNA and phenotype data from Amish families in Ohio and Indiana by examining
and following 800 known and newly identified cognitively normal individuals age 80+ and their 1st and 2nd degree
relatives. We will perform SNP genotyping on all samples and WGS on a subset of 200 cognitively normal
individuals; (2): Identification of AD protective variants. Sibships with multiple individuals who are age 80+
and cognitively normal will be analyzed for genetic linkage, IBD segment sharing, and association. Single-marker
analyses will be supplemented by gene-wise analysis and pathway (gene set-based) analysis; (3): Perform
functional validation of candidate protective variants. These experiments will include screening for effects
on gene expression, impact on Aβ or tau processing, and effects on cellular function.
文摘:
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan L Haines其他文献
Jonathan L Haines的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan L Haines', 18)}}的其他基金
Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL
阿米什人阿尔茨海默病的保护性遗传变异 - RENEWAL
- 批准号:
10448612 - 财政年份:2022
- 资助金额:
$ 28.73万 - 项目类别:
Protective Genetic Variants for Alzheimer Disease in the Amish - RENEWAL
阿米什人阿尔茨海默病的保护性遗传变异 - RENEWAL
- 批准号:
10689703 - 财政年份:2022
- 资助金额:
$ 28.73万 - 项目类别:
Epidemiology of Biomarkers of AMD Progression
AMD 进展生物标志物的流行病学
- 批准号:
10489288 - 财政年份:2021
- 资助金额:
$ 28.73万 - 项目类别:
Protective Genetic Variants for Alzheimer Disease in the Amish
阿米什人阿尔茨海默病的保护性遗传变异
- 批准号:
9439190 - 财政年份:2017
- 资助金额:
$ 28.73万 - 项目类别:
Advancing Genetics Through the AMDgene Consortium
通过 AMDgene 联盟推进遗传学发展
- 批准号:
8265101 - 财政年份:2012
- 资助金额:
$ 28.73万 - 项目类别:
Advancing Genetics Through the AMDgene Consortium
通过 AMDgene 联盟推进遗传学发展
- 批准号:
8449079 - 财政年份:2012
- 资助金额:
$ 28.73万 - 项目类别:
Advancing Genetics Through the AMDgene Consortium
通过 AMDgene 联盟推进遗传学发展
- 批准号:
8655882 - 财政年份:2012
- 资助金额:
$ 28.73万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 28.73万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 28.73万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 28.73万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 28.73万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 28.73万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 28.73万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 28.73万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 28.73万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 28.73万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 28.73万 - 项目类别: